Stay updated with breaking news from Technologies Munich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firms will combine a FAP-targeted molecule with a radioisotope to create a therapy that may treat a variety of cancers.
GARCHING, Germany & MUNICH & HALLE, Germany--(BUSINESS WIRE)--Dec 2, 2021--
Companies will work toward accessing a novel strategy for breaking the tumor microenvironment by combining ITM's high-quality radioisotopes with Navigo's precise target-specific affinity ligands against
Canada’s national nuclear laboratory expands successful Canadian Nuclear Research Initiative to include health sciences stream
Canada’s national nuclear laboratory expands successful Canadian Nuclear Research Initiative to include health sciences stream